Allarity Therapeutics Inc (NASDAQ:ALLR) traded at $1.06 at close of the session on Friday, January 03 and made a downward move of -4.50% on its previous day’s price.
Allarity Therapeutics Inc has a market cap of $4.49 million and is expected to release its quarterly earnings report in February.
On the other hand, looking at the outlook for the ALLR stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 100% Sell.
Based on estimates by 1 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Allarity Therapeutics Inc (ALLR) stock as a Hold, while 1 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 0.43% off its SMA20 and -13.19% from its 50-day simple moving average. The RSI (14) is pointing at 44.73 while the volatility over the past week is 15.55% and jumps to 12.77% over the past one month. The beta value is 0.17, while the average true range (ATR) is currently pointing at 0.14.
Coming back to Allarity Therapeutics Inc (NASDAQ:ALLR), we note that the average 3-month trading volume was 571.19K, while that of the preceding 10-day period stands at 1.48 million. Current shares outstanding are 4.43 million.
The insiders hold 10.67% of the company’s shares while institutions hold 0.49%. The data shows that short shares as of 2024-10-31, stood at 0.18 million at a short ratio of 0.3. This represents a 1270.00 short interest in shares outstanding on 2024-10-31. Shares short rose in October from the previous month at 0.14 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -9.40% down in year-to-date price movement.
